|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
46 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Anti-TNF Strategies |
Edward Abraham |
1997 |
1 | 1 |
p. 19-20 2 p. |
artikel |
|
| 2 | Anti-TNF Strategies |
Abraham, Edward |
1997 |
1 | 1 |
p. 19-20 |
artikel |
|
| 3 | Conclusions |
John C. Marshall |
1997 |
1 | 1 |
p. 55-57 3 p. |
artikel |
|
| 4 | Conclusions |
John C. Marshall |
1997 |
1 | 1 |
p. 75-75 1 p. |
artikel |
|
| 5 | Conclusions |
Marshall, John C. |
1997 |
1 | 1 |
p. 75 |
artikel |
|
| 6 | Conclusions |
Marshall, John C. |
1997 |
1 | 1 |
p. 55-57 |
artikel |
|
| 7 | Defining the Biologic Objectives of Mediator-Directed Therapy: Overview |
John C. Marshall |
1997 |
1 | 1 |
p. 13-13 1 p. |
artikel |
|
| 8 | Defining the Biologic Objectives of Mediator-Directed Therapy: Overview |
Marshall, John C. |
1997 |
1 | 1 |
p. 13 |
artikel |
|
| 9 | Editorial: Sepsis-Rites of Passage |
John C. Marshall |
1997 |
1 | 1 |
p. 5-6 2 p. |
artikel |
|
| 10 | Editorial: Sepsis-Rites of Passage |
Marshall, John C. |
1997 |
1 | 1 |
p. 5-6 |
artikel |
|
| 11 | Fda Perspective on Study Design for Therapies for Severe Sepsis |
William Schwieterman |
1997 |
1 | 1 |
p. 69-69 1 p. |
artikel |
|
| 12 | Fda Perspective on Study Design for Therapies for Severe Sepsis |
Schwieterman, William |
1997 |
1 | 1 |
p. 69 |
artikel |
|
| 13 | How to Assess Organ Dysfunction in the Intensive Care Unit? The Logistic Organ Dysfunction (LOD) System |
Jean-Roger Le Gall |
1997 |
1 | 1 |
p. 45-47 3 p. |
artikel |
|
| 14 | How to Assess Organ Dysfunction in the Intensive Care Unit? The Logistic Organ Dysfunction (LOD) System |
Le Gall, Jean-Roger |
1997 |
1 | 1 |
p. 45-47 |
artikel |
|
| 15 | In Memoriam: Roger C. Bone, M.D. |
John C. Marshall |
1997 |
1 | 1 |
p. 7-10 4 p. |
artikel |
|
| 16 | In Memoriam: Roger C. Bone, M.D. |
Marshall, John C. |
1997 |
1 | 1 |
p. 7-10 |
artikel |
|
| 17 | Measuring the Biological Efficacy of Mediator-Directed Therapy |
Michael R. Pinsky |
1997 |
1 | 1 |
p. 65-67 3 p. |
artikel |
|
| 18 | Measuring the Biological Efficacy of Mediator-Directed Therapy |
Pinsky, Michael R. |
1997 |
1 | 1 |
p. 65-67 |
artikel |
|
| 19 | Mortality as an Outcome in Sepsis Trials |
Paul C. Hébert |
1997 |
1 | 1 |
p. 35-40 6 p. |
artikel |
|
| 20 | Mortality as an Outcome in Sepsis Trials |
Hébert, Paul C. |
1997 |
1 | 1 |
p. 35-40 |
artikel |
|
| 21 | Nitric Oxide Directed Strategies |
Jean-Louis Vincent |
1997 |
1 | 1 |
p. 17-18 2 p. |
artikel |
|
| 22 | Nitric Oxide Directed Strategies |
Vincent, Jean-Louis |
1997 |
1 | 1 |
p. 17-18 |
artikel |
|
| 23 | Organ Dysfunction as an Outcome Measure: The Sofa Score |
Jean-Louis Vincent |
1997 |
1 | 1 |
p. 53-54 2 p. |
artikel |
|
| 24 | Organ Dysfunction as an Outcome Measure: The Sofa Score |
Vincent, Jean-Louis |
1997 |
1 | 1 |
p. 53-54 |
artikel |
|
| 25 | Outcome Measures for Clinical Trials in Sepsis: Introduction |
John C. Marshall |
1997 |
1 | 1 |
p. 11-12 2 p. |
artikel |
|
| 26 | Outcome Measures for Clinical Trials in Sepsis: Introduction |
Marshall, John C. |
1997 |
1 | 1 |
p. 11-12 |
artikel |
|
| 27 | Outcome Measures: Methodologic Principles |
Gordon H. Guyatt |
1997 |
1 | 1 |
p. 21-25 5 p. |
artikel |
|
| 28 | Outcome Measures: Methodologic Principles |
Guyatt, Gordon H. |
1997 |
1 | 1 |
p. 21-25 |
artikel |
|
| 29 | Outcome Measures: Methodologic Principles |
Guyatt, Gordon H. |
|
1 | 1 |
p. 21-25 |
artikel |
|
| 30 | Polyvalent Immunoglobulin |
Günter Pilz |
1997 |
1 | 1 |
p. 15-16 2 p. |
artikel |
|
| 31 | Polyvalent Immunoglobulin |
Pilz, Günter |
1997 |
1 | 1 |
p. 15-16 |
artikel |
|
| 32 | Regulatory Factors in the EUPossible Considerations for the Drug Development Process |
Mair Powell |
1997 |
1 | 1 |
p. 71-73 3 p. |
artikel |
|
| 33 | Regulatory Factors in the EU–Possible Considerations for the Drug Development Process |
Powell, Mair |
1997 |
1 | 1 |
p. 71-73 |
artikel |
|
| 34 | Systematic Review of Outcome Measures in Randomized Trials of Mediator-Directed Therapies in Sepsis |
Maureen O. Meade |
1997 |
1 | 1 |
p. 27-33 7 p. |
artikel |
|
| 35 | Systematic Review of Outcome Measures in Randomized Trials of Mediator-Directed Therapies in Sepsis |
Meade, Maureen O. |
1997 |
1 | 1 |
p. 27-33 |
artikel |
|
| 36 | The Brussels Score |
Gordon Bernard |
1997 |
1 | 1 |
p. 43-44 2 p. |
artikel |
|
| 37 | The Brussels Score |
Bernard, Gordon |
1997 |
1 | 1 |
p. 43-44 |
artikel |
|
| 38 | The Measurement of Organ Dysfunction/Failure as an ICU Outcome |
John C. Marshall |
1997 |
1 | 1 |
p. 41-41 1 p. |
artikel |
|
| 39 | The Measurement of Organ Dysfunction/Failure as an ICU Outcome |
Marshall, John C. |
1997 |
1 | 1 |
p. 41 |
artikel |
|
| 40 | The Microbial Consequences of Antimediator Therapy for Sepsis |
Steven M. Opal |
1997 |
1 | 1 |
p. 59-64 6 p. |
artikel |
|
| 41 | The Microbial Consequences of Antimediator Therapy for Sepsis |
Opal, Steven M. |
1997 |
1 | 1 |
p. 59-64 |
artikel |
|
| 42 | The Microbial Consequences of Antimediator Therapy for Sepsis |
Opal, Steven M. |
|
1 | 1 |
p. 59-64 |
artikel |
|
| 43 | The Multiple Organ Dysfunction (MOD) Score |
John C. Marshall |
1997 |
1 | 1 |
p. 49-52 4 p. |
artikel |
|
| 44 | The Multiple Organ Dysfunction (MOD) Score |
Marshall, John C. |
1997 |
1 | 1 |
p. 49-52 |
artikel |
|
| 45 | Upcoming Events |
1997 |
1 | 1 |
p. 77-77 1 p. |
artikel |
||
| 46 | Upcoming Events |
1997 |
1 | 1 |
p. 77 |
artikel |
46 gevonden resultaten